Metraipolis › archive › dc_4ebf9bada4a4
Real-World Effectiveness of Tezepelumab in Severe Asthma: A Comparative Analysis of High and Low T2 Phenotypes — Europe PMC PMID:41893035
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41893035
- DOI
- 10.3390/jpm16030167
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T06:46:50.910Z
- SHA-256 of the archived text
781f54342ddab046c943530ce984ed62f87aeca6bc5b5530fac61bc1343e4d1f- Stable URL of this page
https://metraipolis.com/documento/dc_4ebf9bada4a4
How to cite
Real-World Effectiveness of Tezepelumab in Severe Asthma: A Comparative Analysis of High and Low T2 Phenotypes — Europe PMC PMID:41893035 — Europe PMC (en), https://europepmc.org/article/MED/41893035 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ebf9bada4a4 (Metraipolis archive dc_4ebf9bada4a4, sha256 781f54342ddab046c943530ce984ed62f87aeca6bc5b5530fac61bc1343e4d1f)
BibTeX
@misc{dc4ebf9bada4a4,
title = {Real-World Effectiveness of Tezepelumab in Severe Asthma: A Comparative Analysis of High and Low T2 Phenotypes — Europe PMC PMID:41893035},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41893035},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ebf9bada4a4; sha256 781f54342ddab046c943530ce984ed62f87aeca6bc5b5530fac61bc1343e4d1f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41893035. Agents can read the archived copy with the MCP tool read_document.